Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 45 studies | 55% ± 17% | |
| endothelial cell | 31 studies | 33% ± 14% | |
| pericyte | 28 studies | 36% ± 17% | |
| smooth muscle cell | 26 studies | 35% ± 16% | |
| connective tissue cell | 20 studies | 52% ± 23% | |
| myofibroblast cell | 15 studies | 48% ± 17% | |
| mesothelial cell | 9 studies | 38% ± 17% | |
| adipocyte | 9 studies | 41% ± 20% | |
| astrocyte | 9 studies | 28% ± 12% | |
| endothelial cell of artery | 8 studies | 33% ± 15% | |
| vein endothelial cell | 8 studies | 35% ± 18% | |
| endothelial cell of vascular tree | 7 studies | 21% ± 8% | |
| epithelial cell | 7 studies | 31% ± 10% | |
| ciliated cell | 7 studies | 28% ± 11% | |
| cardiac muscle cell | 6 studies | 30% ± 11% | |
| glial cell | 5 studies | 31% ± 15% | |
| adventitial cell | 5 studies | 68% ± 14% | |
| Mueller cell | 5 studies | 29% ± 7% | |
| capillary endothelial cell | 4 studies | 30% ± 10% | |
| type I pneumocyte | 4 studies | 29% ± 8% | |
| luminal cell of prostate epithelium | 4 studies | 24% ± 2% | |
| progenitor cell | 3 studies | 44% ± 14% | |
| extravillous trophoblast | 3 studies | 67% ± 1% | |
| basal cell | 3 studies | 22% ± 6% | |
| lymphocyte | 3 studies | 20% ± 1% | |
| muscle cell | 3 studies | 24% ± 3% | |
| pancreatic ductal cell | 3 studies | 37% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 30163.41 | 244 / 245 | 99% | 239.06 | 498 / 502 |
| breast | 100% | 43493.12 | 459 / 459 | 97% | 151.48 | 1079 / 1118 |
| lung | 100% | 28486.65 | 577 / 578 | 93% | 96.38 | 1070 / 1155 |
| bladder | 100% | 33757.95 | 21 / 21 | 85% | 82.93 | 429 / 504 |
| thymus | 99% | 20013.87 | 647 / 653 | 83% | 55.64 | 502 / 605 |
| uterus | 99% | 29705.19 | 169 / 170 | 81% | 120.62 | 370 / 459 |
| adrenal gland | 98% | 21776.98 | 253 / 258 | 78% | 59.63 | 180 / 230 |
| intestine | 89% | 27795.20 | 860 / 966 | 83% | 76.67 | 438 / 527 |
| skin | 85% | 46684.21 | 1541 / 1809 | 86% | 105.25 | 406 / 472 |
| ovary | 97% | 18627.95 | 175 / 180 | 71% | 50.74 | 304 / 430 |
| esophagus | 80% | 29407.06 | 1150 / 1445 | 88% | 82.22 | 161 / 183 |
| kidney | 54% | 7300.28 | 48 / 89 | 89% | 154.12 | 798 / 901 |
| stomach | 52% | 12798.35 | 188 / 359 | 86% | 88.49 | 246 / 286 |
| pancreas | 8% | 824.41 | 27 / 328 | 96% | 173.93 | 171 / 178 |
| adipose | 100% | 61859.80 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 53626.78 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 61.33 | 1 / 1 |
| heart | 97% | 26839.88 | 833 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 78% | 62.04 | 35 / 45 |
| spleen | 77% | 9876.24 | 185 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 30.31 | 17 / 29 |
| eye | 0% | 0 | 0 / 0 | 55% | 28.91 | 44 / 80 |
| brain | 3% | 264.61 | 82 / 2642 | 50% | 50.07 | 356 / 705 |
| liver | 4% | 456.45 | 10 / 226 | 26% | 16.15 | 105 / 406 |
| muscle | 15% | 1551.08 | 121 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 7.11 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030510 | Biological process | regulation of BMP signaling pathway |
| GO_0007275 | Biological process | multicellular organism development |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0030154 | Biological process | cell differentiation |
| GO_0043542 | Biological process | endothelial cell migration |
| GO_0045446 | Biological process | endothelial cell differentiation |
| GO_0061484 | Biological process | hematopoietic stem cell homeostasis |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0008201 | Molecular function | heparin binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FSTL1 |
| Protein name | Follistatin-related protein 1 (Follistatin-like protein 1) Follistatin like 1 |
| Synonyms | FRP |
| Description | FUNCTION: Secreted glycoprotein that is involved in various physiological processes, such as angiogenesis, regulation of the immune response, cell proliferation and differentiation . Plays a role in the development of the central nervous system, skeletal system, lungs, and ureter (By similarity). Promotes endothelial cell survival, migration and differentiation into network structures in an AKT-dependent manner. Also promotes survival of cardiac myocytes (By similarity). Initiates various signaling cascades by activating different receptors on the cell surface such as DIP2A, TLR4 or BMP receptors . . |
| Accessions | ENST00000480823.1 Q12841 ENST00000469005.2 [Q12841-1] ENST00000469005.1 ENST00000710954.1 [Q12841-1] C9J5G4 ENST00000424703.6 [Q12841-2] H7C4W4 ENST00000295633.8 [Q12841-1] |